Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merlo

Showing results (81-90 of 431) with videos related to

Pageof 44
Sort By:
Heart, Lung & Circulation|March 15, 2013
Long term survival in patients with cardiac amyloidosis. Prevalence and characterisation during follow-upGherardo Finocchiaro, Marco Merlo, Bruno Pinamonti, et al.
European Journal of Internal Medicine|June 6, 2021
Combining New Classes of Drugs for HFrEF: from Trials to Clinical PracticeGianfranco Sinagra, Linda Pagura, Davide Stolfo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 16, 2019
ECG in dilated cardiomyopathy: specific findings and long-term prognostic significanceMarco Merlo, Denise Zaffalon, Davide Stolfo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 22, 2025
Cardiac amyloidosis: when to suspect and how to confirmMichele Emdin, Alberto Aimo, Yu Fu Ferrari Chen, et al.
Heart Failure Clinics|March 13, 2025
Advances in the Therapy of Light Chain Cardiac AmyloidosisGiuseppe Palmiero, Paolo Milani, Federica Verrillo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 31, 2015
Pulmonary artery aneurysm and sarcoidosisRiccardo Gerloni, Marco Merlo, Giancarlo Vitrella, et al.
European Heart Journal. Case Reports|March 13, 2023
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentationVincenzo Nuzzi, Aldostefano Porcari, Marta Gigli, et al.
Clinical Medicine & Research|August 5, 2010
Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of TriesteAneta Aleksova, Marco Merlo, Massimo Zecchin, et al.
European Journal of Heart Failure|January 28, 2014
Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 yearsMarco Merlo, Alberto Pivetta, Bruno Pinamonti, et al.
International Journal of Cardiology|June 13, 2019
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entityGiuseppe D Sanna, Marco Merlo, Eleonora Moccia, et al.
Pageof 44

Showing results (81-90 of 431) with videos related to

Sort By:
Pageof 44
Heart, Lung & Circulation|March 15, 2013
Long term survival in patients with cardiac amyloidosis. Prevalence and characterisation during follow-upGherardo Finocchiaro, Marco Merlo, Bruno Pinamonti, et al.
European Journal of Internal Medicine|June 6, 2021
Combining New Classes of Drugs for HFrEF: from Trials to Clinical PracticeGianfranco Sinagra, Linda Pagura, Davide Stolfo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 16, 2019
ECG in dilated cardiomyopathy: specific findings and long-term prognostic significanceMarco Merlo, Denise Zaffalon, Davide Stolfo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 22, 2025
Cardiac amyloidosis: when to suspect and how to confirmMichele Emdin, Alberto Aimo, Yu Fu Ferrari Chen, et al.
Heart Failure Clinics|March 13, 2025
Advances in the Therapy of Light Chain Cardiac AmyloidosisGiuseppe Palmiero, Paolo Milani, Federica Verrillo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 31, 2015
Pulmonary artery aneurysm and sarcoidosisRiccardo Gerloni, Marco Merlo, Giancarlo Vitrella, et al.
European Heart Journal. Case Reports|March 13, 2023
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentationVincenzo Nuzzi, Aldostefano Porcari, Marta Gigli, et al.
Clinical Medicine & Research|August 5, 2010
Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of TriesteAneta Aleksova, Marco Merlo, Massimo Zecchin, et al.
European Journal of Heart Failure|January 28, 2014
Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 yearsMarco Merlo, Alberto Pivetta, Bruno Pinamonti, et al.
International Journal of Cardiology|June 13, 2019
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entityGiuseppe D Sanna, Marco Merlo, Eleonora Moccia, et al.
Pageof 44